Sveriges mest populära poddar

Gene Editing: The Future of Genomic Medicine & Biotech Investing

18 min•23 mars 2022

Om avsnittet

In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt

Exchanges med Goldman Sachs finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.

Gene Editing: The Future of Genomic Medicine & Biotech Investing

Om avsnittet

Fler avsnitt

Why Oil Prices Are Surging Despite Recovering Supply

Where Chinese Exports Are Gaining the Most Market Share

Inside the Revival of Venture Capital Liquidity with an Industry Pioneer

How Family Businesses Should Plan for Generational Success

Why Markets May Be Pricing in Too Many Fed Rate Hikes

Rich Friedman on the Rise of Private Markets and AI Investing

Why Global Bond Yields Are Surging

How Will Less Fed Transparency Affect Markets and the Economy?

Dipan Patel on Permira’s ‘Artisanal’ Approach to Private Equity

The Outlook for Data Center Power Demand as AI Token Use Grows